it beats me, the bashers say read the last 10k,bk,ceo gone, lawsuits on horizon for deaths/shareholders
the longs say no,no,no 10k is the name for a new affy drug to replace o removal from the market
10k is in phase one trials and should hit market by 2017, longs say we don't need cash flow, we don't need a ceo and just keep averaging down.........
I know, no one knows what exactly is going on. but then again thats like any stock. Only difference here is that there is so much more to gain and so much to lose.
The reason i asked about the ARS filling is because i cannot open it.